Literature DB >> 24166346

Kidney cancer: Characterizing late recurrence of renal cell carcinoma.

Vincenzo Ficarra1, Giacomo Novara.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24166346     DOI： 10.1038/nrurol.2013.239

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  5 in total

Review 1.  Prognostic and therapeutic impact of the histopathologic definition of parenchymal epithelial renal tumors.

Authors:  Vincenzo Ficarra; Matteo Brunelli; Liang Cheng; Ziya Kirkali; Antonio Lopez-Beltran; Guido Martignoni; Rodolfo Montironi; Giacomo Novara; Hein Van Poppel
Journal:  Eur Urol       Date:  2010-08-10       Impact factor: 20.096

Review 2.  Prognostic factors and predictive models in renal cell carcinoma: a contemporary review.

Authors:  Maxine Sun; Shahrokh F Shariat; Christopher Cheng; Vincenzo Ficarra; Masaru Murai; Stéphane Oudard; Allan J Pantuck; Richard Zigeuner; Pierre I Karakiewicz
Journal:  Eur Urol       Date:  2011-06-30       Impact factor: 20.096

3.  Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).

Authors:  Sabine Brookman-May; Matthias May; Shahrokh F Shariat; Evanguelos Xylinas; Christian Stief; Richard Zigeuner; Thomas Chromecki; Maximilian Burger; Wolf F Wieland; Luca Cindolo; Luigi Schips; Ottavio De Cobelli; Bernardo Rocco; Cosimo De Nunzio; Bogdan Feciche; Michael Truss; Christian Gilfrich; Sascha Pahernik; Markus Hohenfellner; Stefan Zastrow; Manfred P Wirth; Giacomo Novara; Marco Carini; Andrea Minervini; Claudio Simeone; Alessandro Antonelli; Vincenzo Mirone; Nicola Longo; Alchiede Simonato; Giorgio Carmignani; Vincenzo Ficarra
Journal:  Eur Urol       Date:  2012-06-22       Impact factor: 20.096

4.  Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma--results from a comprehensive multi-centre database (CORONA/SATURN-Project).

Authors:  Sabine D Brookman-May; Matthias May; Shahrokh F Shariat; Giacomo Novara; Richard Zigeuner; Luca Cindolo; Ottavio De Cobelli; Cosimo De Nunzio; Sascha Pahernik; Manfred P Wirth; Nicola Longo; Alchiede Simonato; Sergio Serni; Salvatore Siracusano; Alessandro Volpe; Giuseppe Morgia; Roberto Bertini; Orietta Dalpiaz; Christian Stief; Vincenzo Ficarra
Journal:  BJU Int       Date:  2013-07-25       Impact factor: 5.588

5.  Survival outcome and treatment response of patients with late relapse from renal cell carcinoma in the era of targeted therapy.

Authors:  Nils Kroeger; Toni K Choueiri; Jae-Lyn Lee; Georg A Bjarnason; Jennifer J Knox; Mary J MacKenzie; Lori Wood; Sandy Srinivas; Ulka N Vaishamayan; Sun-Young Rha; Sumanta K Pal; Takeshi Yuasa; Frede Donskov; Neeraj Agarwal; Min-Han Tan; Aristotelis Bamias; Christian K Kollmannsberger; Scott A North; Brian I Rini; Daniel Y C Heng
Journal:  Eur Urol       Date:  2013-07-30       Impact factor: 20.096
  5 in total
  3 in total

Review 1.  Surgical Management of Local Recurrences of Renal Cell Carcinoma.

Authors:  Ömer Acar; Öner Şanlı
Journal:  Surg Res Pract       Date:  2016-01-26

2.  Partial nephrectomy and positive surgical margin, oncologic outcomes and predictors: a 15-year single institution experience.

Authors:  Mohammad Hadi Radfar; Fatemeh Ameri; Mehdi Dadpour; Reza Khabazian; Nasrin Borumandnia; Sajjad Askarpour Kabir
Journal:  Cent European J Urol       Date:  2021-12-06

3.  TRIM47 promotes malignant progression of renal cell carcinoma by degrading P53 through ubiquitination.

Authors:  Jia-Xin Chen; Da Xu; Jian-Wei Cao; Li Zuo; Zhi-Tao Han; Yi-Jun Tian; Chuan-Min Chu; Wang Zhou; Xiu-Wu Pan; Xin-Gang Cui
Journal:  Cancer Cell Int       Date:  2021-02-23       Impact factor: 5.722
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.